v3 Template
M
Miromatrix Medical Inc.
Biotechnology / Healthcare
Founded
--
Employees
--
Total Funding
$10.0M
Funding Rounds
1
Last Funding
2023-03-07
About Miromatrix Medical Inc.
Miromatrix is a company focused on bioengineering human organs for transplantation, with a mission to eliminate the organ transplant waitlist. They aim to provide new options for thousands of patients in need of life-saving transplants by developing fully transplantable human organs using their patented technology.
Products & Services
Bioengineered Human Organs:Developing fully transplantable human organs using proprietary perfusion decellularization and recellularization technology, which involves removing cells from pig organs and repopulating them with human cells.
miroliver*ELAP*(r), mirokidney(r), miroliver(r):Investigational products for organ transplantation, currently not FDA cleared or approved.
Specialties
Bioengineering Organs
Regenerative Medicine
Perfusion Decellularization
Perfusion Recellularization
Organ Transplantation
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Public Offering T: - FT: Public Offering |
A: 10000000 MR: - FA: 10.0 million FAN: 10000000 |
D: 2023-03-07 FD: 2023-03-07 |
2 investors |
Public Offering
Latest
2023-03-07
$10.0M
2 investors (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Miromatrix Medical Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- miromatrix.com
- Industries
- Biotechnology / Healthcare
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro